Dr. Shoamanesh is an investigator with the Stroke and Cognition Program at the Population Health Research Institute and Hamilton Health Sciences. He is a Stroke Neurologist who completed his fellowship training at the Boston University School of Medicine and Harvard Medical School in 2014. He is an Assistant Professor of Medicine (Neurology) at McMaster University, where he holds the Marta and Owen Boris Chair in Stroke Research and Care and serves as Director of the Stroke Fellowship Program.
His main research focus is the characterization of hemorrhage-prone cerebral small vessel disease and the optimization of clinical care in this patient population. Dr. Shoamanesh is currently a consultant within the Framingham Heart Study and works in the Project Teams for the NAVIGATE ESUS, COMPASS MIND and INVICTUS trials. He is Co-Principal Investigator of the NASPAF-ICH trial, which is a phase II multicenter randomized controlled trial investigating optimal antithrombotic therapy in patients with high-risk atrial fibrillation and previous intracerebral hemorrhage. He has published over 85 manuscripts and abstracts, and his work has been recognized by, amongst others, the 2014 European Stroke Conference Young Investigator Award and the 2015 Mordecai Y.T. Globus New Investigator Award, which is awarded by the American Heart/Stroke Association in recognition of Dr. Mordecai Y.T. Globus’ major contributions to research in cerebrovascular disease.
Publications are listed in chronological order by descending date. Link takes user to pubMed for publication details.